Hosted on MSN
Lack of benefit from left atrial appendage occlusion for some patients after valvular surgery
No benefit in terms of prevention of ischemic stroke, transient ischemic attack and cardiovascular mortality after 1 year was observed when surgical left atrial appendage occlusion was performed in ...
On the first day of the 2016 CardioStim sessions, I am happy to report a "positive" study on percutaneous left atrial appendage closure [1]. Notice I did not write Watchman. In Europe, the majority of ...
Please provide your email address to receive an email when new articles are posted on . OPTION is a head-to-head trial of left atrial appendage closure with Watchman FLX vs. anticoagulation after ...
CHICAGO -- For patients at high risk of stroke who underwent catheter-based atrial fibrillation ablation, left atrial appendage closure led to less bleeding compared with oral anticoagulation, the ...
The current bias of medicine is strong. When we are in doubt, when evidence is sparse, doctors do more, not less. Internists prescribe, cardiologists implant, surgeons cut. We know what we know. So it ...
Hosted on MSN
Multi-society recommendations to guide transcatheter left atrial appendage occlusion for stroke prevention
The Society for Cardiovascular Angiography & Interventions (SCAI) and the Heart Rhythm Society (HRS) have published the first rigorous, evidence-based, multisociety recommendations to guide the use of ...
Please provide your email address to receive an email when new articles are posted on . In patients with atrial fibrillation and high risk for stroke and bleeding, left atrial appendage occlusion was ...
Medtronic has secured a CE mark approval in Europe for its surgical implant to close the heart’s left atrial appendage, aimed at reducing the long-term risk of stroke that’s higher among people with ...
Atrial fibrillation (AF) is the most common sustained cardiac arrhythmia and remains a significant contributor to morbidity and mortality worldwide. A central focus of current research is the left ...
Data also demonstrates that the stroke risk reduction device is as effective as oral anticoagulants for patients with atrial fibrillation following a cardiac ablation The trial met the primary safety ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results